IFM Investors Pty Ltd lifted its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 5.5% in the 1st quarter, Holdings Channel.com reports. The firm owned 39,257 shares of the semiconductor company’s stock after acquiring an additional 2,034 shares during the quarter. IFM Investors Pty Ltd’s holdings in Synopsys were worth $15,565,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. North Point Portfolio Managers Corp OH increased its holdings in shares of Synopsys by 20.3% in the 1st quarter. North Point Portfolio Managers Corp OH now owns 33,351 shares of the semiconductor company’s stock valued at $13,223,000 after acquiring an additional 5,627 shares during the period. Wendell David Associates Inc. lifted its stake in shares of Synopsys by 55.0% during the 1st quarter. Wendell David Associates Inc. now owns 7,400 shares of the semiconductor company’s stock worth $2,934,000 after purchasing an additional 2,626 shares during the last quarter. Impact Partnership Wealth LLC boosted its position in Synopsys by 16.0% during the first quarter. Impact Partnership Wealth LLC now owns 718 shares of the semiconductor company’s stock valued at $285,000 after purchasing an additional 99 shares in the last quarter. Caliber Wealth Management LLC KS grew its stake in Synopsys by 28.0% in the first quarter. Caliber Wealth Management LLC KS now owns 4,047 shares of the semiconductor company’s stock valued at $1,605,000 after purchasing an additional 886 shares during the last quarter. Finally, EWA LLC grew its stake in Synopsys by 18.6% in the first quarter. EWA LLC now owns 562 shares of the semiconductor company’s stock valued at $223,000 after purchasing an additional 88 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors.
Synopsys Trading Up 1.9%
NASDAQ:SNPS opened at $454.53 on Thursday. The company has a market capitalization of $87.03 billion, a P/E ratio of 105.22, a PEG ratio of 2.62 and a beta of 1.22. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 12 month low of $376.18 and a 12 month high of $651.73. The firm has a fifty day simple moving average of $483.60 and a 200-day simple moving average of $461.62.
Insider Transactions at Synopsys
In related news, CEO Sassine Ghazi sold 14,603 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the sale, the chief executive officer owned 75,020 shares in the company, valued at $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the transaction, the chief financial officer owned 14,358 shares in the company, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
SNPS has been the subject of several analyst reports. BNP Paribas Exane increased their price target on shares of Synopsys from $425.00 to $450.00 and gave the company an “underperform” rating in a research report on Thursday, May 28th. Robert W. Baird set a $558.00 price objective on shares of Synopsys in a research report on Thursday, May 28th. Stifel Nicolaus boosted their price objective on shares of Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Needham & Company LLC reissued a “buy” rating and set a $580.00 target price on shares of Synopsys in a research report on Thursday, May 28th. Finally, KeyCorp reaffirmed an “overweight” rating on shares of Synopsys in a report on Thursday, May 28th. Ten analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Synopsys currently has an average rating of “Moderate Buy” and a consensus target price of $570.06.
View Our Latest Report on SNPS
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
